
Episode 96: Could Durable LVADs be an Intentional First-Line Strategy?
JHLT: The Podcast returns to the heart side this month with a State of the Art paper published earlier this year in JHLT and now available in the November print issue. First author Alexander M. Bernhardt, MD, ISHLTF, of the University Heart and Vascular Center in Hamburg Germany, joins the podcast to discuss "Net prolongation of life in advanced heart failure: An intentional strategy of durable LVAD therapy followed by heart transplantation." In their discussion, they cover: Incorporating long-term consequences of transplantation into today's treatment decisions Characteristics of patients that may be suited for this approach Comparable outcomes in LVAD weaning Upcoming studies and results that expand this idea beyond registry data For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.


















